Aligos Therapeutics (ALGS) Earnings Analysis
Aligos Therapeutics (ALGS) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -2.21 USD vs -2.29 USD est (+3.5%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -0.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ALGS next report earnings?
No confirmed upcoming earnings date is currently scheduled for ALGS. This page updates as the calendar is published.
ALGS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -2.21 USD | -2.29 USD | +3.5% | Beat |
| 2026-03-05 | -1.91 USD | -2.48675 USD | +23.2% | Beat |
| 2025-11-06 | -3.04 USD | -2.09 USD | -45.5% | Miss |
| 2025-03-10 | -3.41 USD | -2.63 USD | -29.7% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
ALGS valuation and analyst view
| Trailing P/E | -0.59 |
|---|---|
| Trailing EPS | -8.68223 USD |
| Price / book | 1.69 |
| Dividend yield | 0.00% |
| Market cap | 0.03B |
| Analyst consensus | Buy (3 buy / 2 hold / 0 sell) |
| Avg price target | 20 USD |
Related research pages
Frequently asked questions
When is Aligos Therapeutics (ALGS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ALGS. This page updates as the calendar is published.
Did ALGS beat earnings last quarter?
In its 2026-05-07 report, ALGS posted EPS of -2.21 USD versus a -2.29 USD estimate — a beat of 3.5%.
What is ALGS's earnings track record?
Over the last 4 reported quarters with consensus data, ALGS beat estimates 2 times (50%).
What is ALGS's current P/E ratio and EPS?
ALGS trades at a trailing P/E of -0.59 on trailing EPS of -8.682234597110613 USD.
What do analysts rate ALGS?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 20 USD.